14.06.2016 • News

Joseph Barendt new President of Chiral Technologies

Chiral Technologies, a unit of Japan’s Daicel specialized in enantioselective chromatography, has appointed Joseph M. Barendt as its new president.

Prior to the appointment, Barendt, who earned a Ph.D in chemistry from the University of Colorado and an MBA from the Joseph M. Katz School of Business at the University of Pittsburgh – both in the US –   served as the company’s chief operating officer.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

March 24, 2026 | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

most read